Mednax Inc (MD) : The total money flow in Mednax Inc (MD) was negative ($10.53 million), which signals selling by the traders on Tuesdays session. They trimmed their holdings by selling the stock on downticks to the tune of $20.36 million. In comparison, the inflow of money into the stock on upticks was $9.83 million. The uptick to downtick ratio was 0.48. Similarly, the block trades show selling by large traders on strength. The value of stocks sold down on downtick was $10.54 million. The negative money flow of ($10.54 million) confirms the selling in Mednax Inc (MD) on strength. Mednax Inc (MD) gained $0.71 at $65.89, a gain of 1.09% over the previous days close. However, the stock registered 5.04% in the week.
Also, Brokerage firm Jefferies maintains its rating on Mednax Inc (NYSE:MD). As per the latest information, the brokerage house lowers the price target to $75 per share from a prior target of $80. The shares have been rated Buy. The rating by the firm was issued on August 26, 2016.
Shares of MEDNAX, Inc. appreciated by 1.56% during the last five trading days but lost 4.49% on a 4-week basis. MEDNAX, Inc. has dropped 3.09% during the last 3-month period . Year-to-Date the stock performance stands at -8.05%.
Mednax Inc (NYSE:MD): During Tuesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $65.10 and $65.10 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $66.40. The buying momentum continued till the end and the stock did not give up its gains. It closed at $65.89, notching a gain of 1.09% for the day. The total traded volume was 914,128 . The stock had closed at $65.18 on the previous day.
In a related news, Andreano Dominic J, officer (SVP, General Counsel and Secy) of Mednax, Inc., unloaded 3,922 shares at an average price of $68.8 on June 13, 2016. The total amount of the transaction was worth $269,834, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
MEDNAX, Inc. (MEDNAX) is a provider of physician services, including newborn, maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units, primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals, 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists and pediatric surgeons.